CompletedNot applicableNCT03576235
Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients
Studying Uremic pruritus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seoul National University Boramae Hospital
- Principal Investigator
- Chun Soo Lim, MD, PhD, DDSSeoul National University Boramae Medical Center, Seoul, Republic of Korea.
- Intervention
- PG102P(drug)
- Enrollment
- 80 target
- Eligibility
- 19 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- Seoul National University Boramae Medical Center, Seoul, South Korea
Collaborators
Seoul National University Hospital · Seoul National University Bundang Hospital · Ewha Womans University Mokdong Hospital · Severance Hospital · Chungnam National University Hospital · Gachon University Gil Medical Center · Kyungpook National University Hospital · DongGuk University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03576235 on ClinicalTrials.govOther trials for Uremic pruritus
Additional recruiting or active studies for the same condition.